Get started
Author

Salvatore Artale

Observed names: Artale, Salvatore, S Artale, S. Artale
ORCID: 0009-0009-1077-4978
Observed ORCID: 0009-0009-1077-4978
OpenAlex ID: A5085230472
Tas-102 for Refractory Metastatic Colorectal Cancer: A Multicenter Retrospective Cohort Study
2023 · Matteo Conti, Elena Bolzacchini, et al. · Cancers · 6
PDF
Financial Consequences of The Performance of A Pd-L1 Test To Select Patients Receiving Second and Third Line Treatments for Non-Small Cell Lung Cancer in Italy
2017 · U Restelli, S Artale, et al. · Value in Health · 1
The Effects of a Modified Mediterranean Diet on Gut Microbiota and Chemotherapy Side Effects in Patients With Metastatic Colorectal Cancer Undergoing First-Line Chemotherapy With or Without Either Antiepidermal Growth Factor Receptor or Antivascular Endothelial Growth Factor Agent: Protocol for a Randomized Pilot Study in Italy
2025 · Salvatore Artale, Francesca Filiali, et al. · JMIR Research Protocols
Correction 2: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study
2018 · Cazzaniga, Marina, Verusio, Claudio, et al. · Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna)
Preliminary Experience of Imatinib after Nilotinib in the First Line Treatment of Chronic Myeloid Leukemia
2017 · Ester Pungolino, Mariella D’Adda, et al. · BOA (University of Milano-Bicocca)
Multicenter retrospective study on new biomarkers predictive of response to sunitinib in metastatic renal cell carcinoma
2016 · G. Pinotti, E. Bolzacchini, et al. · Annals of Oncology
[Multiparameter analysis of the ergometric test. Significance of the failure of systolic blood pressure to decrease during recovery phase as an index of coronary disease].
1990 · G Doria, G Scaccianoce, et al. · PubMed
Works count: 7
Citation count: 7
H-index: 1
I10-index:
Year
Topic
Type